Recent Report on Global Gastrointestinal Therapeutics Market 2016-2020

Report: Global Gastrointestinal Therapeutics Market 2016-2020 is a new market research publication announced by Reportstack.

Report Outline: Gastrointestinal disorders include both functional and motility disorders affecting the gastrointestinal tract. Functional disorders involve an abnormality in the working of the gastrointestinal tract. They are the most common type of disorders and present with disturbances in motility, visceral hypersensitivity, changes in the mucosal and immune function, variations in central nervous system processing, and altered gut microbiota. Motility disorders are characterized by changes in the movement of the gastrointestinal tract and the transfer of its contents. Some of the most common gastrointestinal functional and motility disorders include IBS, GERD, Crohn’s disease, ulcerative colitis, and peptic ulcers.

For detailed report with TOC, please click here ​Global Gastrointestinal Therapeutics Market 2016-2020.

Market Growth: The global gastrointestinal therapeutics market is expected to grow at a CAGR of 6.5% during the period 2016-2020.

Key vendors • AbbVie
• Johnson & Johnson
• Takeda
• Allergan
• UCB

Other prominent vendors • 4SC
• Ajinomoto Pharmaceuticals
• Alfa Wassermann
• Alizyme
• Amgen
• Anterogen
• Ardelyx
• Arena Pharmaceuticals
• Astellas
• AstraZeneca
• Astellas Pharma
• Avaxia Biologics
• Biogen Idec
• BioLineRx
• Celgene
• ChemoCentryx
• Cosmo Pharmaceuticals
• Drais Pharmaceuticals
• Eisai
• Eli Lilly
• Enlivex Therapeutics
• F. Hoffmann-La Roche
• Ferring Pharmaceuticals
• FF Pharma
• Galapagos
• Gilead Sciences
• GlaxoSmithKline
• Hutchison Medi Pharma
• Immune Pharmaceuticals
• InDex Pharmaceuticals
• Ironwood Pharmaceuticals
• Kaken Pharmaceutical
• Kang Stem Biotech
• Kissei Pharmaceutical
• Kyowa Hakko Kirin
• Lexicon Pharmaceuticals
• Lipid Therapeutics,etc.

Regions Covered: 

• Americas
• APAC
• EMEA

Companies Mentioned

AbbVie, Johnson & Johnson, Takeda, Allergan, UCB, 4SC, Ajinomoto Pharmaceuticals, Alfa Wassermann, Alizyme, Amgen, Anterogen, Ardelyx, Arena Pharmaceuticals, Astellas, AstraZeneca, Astellas Pharma, Avaxia Biologics, Biogen Idec, BioLineRx, Celgene, ChemoCentryx, Cosmo Pharmaceuticals, Drais Pharmaceuticals, Eisai, Eli Lilly, Enlivex Therapeutics, F. Hoffmann-La Roche, Ferring Pharmaceuticals, FF Pharma, Galapagos, Gilead Sciences, GlaxoSmithKline, Hutchison Medi Pharma, Immune Pharmaceuticals, InDex Pharmaceuticals, Ironwood Pharmaceuticals, Kaken Pharmaceutical, Kang Stem Biotech, Kissei Pharmaceutical, Kyowa Hakko Kirin, Lexicon Pharmaceuticals, Lipid Therapeutics, Meda, Merck, Mesoblast, Mitsubishi Tanabe, Mochida Pharmaceutical, Morphotek, Neovacs, Nestle, Norgine, Novartis, Ono Pharmaceutical, Pfizer, Procter & Gamble, Qu Biologics, Receptos, RedHill Biopharma, Salix Pharmaceuticals, Shield Therapeutics, Sterna Biologicals, Synergy Pharmaceuticals, Synthetic Biologics, TiGenix, Tillotts Pharma, TopiVert, TSD Japan, Zeria Pharmaceutical.

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

Reportstack Market Research

###